Keyphrases
Non-small Cell Lung Cancer (NSCLC)
100%
Chemotherapy
100%
Adjuvant Chemotherapy
100%
Recent Trends
100%
Stage II-III
100%
Trends in Use
100%
Age Groups
33%
Multivariate Analysis
33%
Elderly People
33%
Young Age
16%
Randomized Trial
16%
5-year Survival
16%
Univariate Analysis
16%
Surveillance Epidemiology
16%
Survival Benefit
16%
Early-stage Lung Cancer
16%
End Results Database
16%
American Joint Committee on Cancer
16%
Medicine and Dentistry
Non Small Cell Lung Cancer
100%
Adjuvant Chemotherapy
100%
Multivariate Analysis
40%
Elderly Population
40%
Malignant Neoplasm
20%
Overall Survival
20%
Univariate Analysis
20%
Surveillance, Epidemiology, and End Results
20%
Pharmacology, Toxicology and Pharmaceutical Science
Non Small Cell Lung Cancer
100%
Chemotherapy
100%
Malignant Neoplasm
10%
Overall Survival
10%
Patient History of Chemotherapy
10%
Agricultural and Biological Sciences
Lung
100%
Multivariate Analysis
50%
Americans
25%
Committees
25%